Procurement Summary
Country: Kazakhstan
Summary: Purchase of Medicines, Amt: 1489550.00
Deadline: 20 Feb 2026
Posting Date: 20 Feb 2026
Other Information
Notice Type: Tender
TOT Ref.No.: 136245537
Document Ref. No.: 16362381-1
Financier: Self Financed
Purchaser Ownership: Public
Tender Value: KZT 1489550.00
Purchaser's Detail
Name: Login to see tender_details
Address: Login to see tender_details
Email: Login to see tender_details
Login to see detailsTender Details
Lots: Povidone-Iodine - 10% 100ml. Solution for external and local use. A/v-povidone-iodine 10.0 g (in terms of active iodine - 1.0 g). Purified IV water up to 100.0 ml. With an expiration date of at least December 2027. List of documents required for receipt of medicines, medical devices: certificate of conformity of products (when declaring), certifying that this drug, medical device has passed a quality assessment; Registration Certificate of the Republic of Kazakhstan, certifying that this drug, medical device registered and approved for use on the territory of the Republic of Kazakhstan. If a medicinal product or medical device is not registered in the Republic of Kazakhstan, then an import permit is required." | Ketoprofen - 100 mg / 2 ml No. 5, solution for injection. A/B-ketoprofen (in calculated as 100% substance) 100 mg. B/W-propylene glycol, ethanol, benzyl alcohol, sodium metabisulfite, sodium hydroxide, sodium hydroxide 1M solution, water for injection. With an expiration date of at least December 2027. List of documents required for receipt of medicines, medical devices: certificate of conformity of products (when declaring), certifying that this drug, medical device has passed a quality assessment; Registration Certificate of the Republic of Kazakhstan, certifying that this drug, medical device registered and approved for use on the territory of the Republic of Kazakhstan. If a medicinal product or medical device is not registered in the Republic of Kazakhstan, then an import permit is required." | Furazidin - 50 mg No. 30...
Documents
Tender Notice